Thymosin β£ 1 (Tβ£) is an immune modifier that has been shown in a pilot study to be effective for chronic hepatitis B; this requires confirmation. Ninety-eight patients with clinicopathologically proven chronic hepatitis B were randomly allocated to 3 groups: 1) group A received a 26-week course of T
A randomized controlled trial of a community nursesupported hospital discharge programme in older patients with chronic heart failure1
β Scribed by Berry Middel; T. Kwok; J. Lee; DTF Lee
- Publisher
- Springer-Verlag
- Year
- 2008
- Weight
- 150 KB
- Volume
- 6
- Category
- Article
- ISSN
- 1572-2082
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
## Abstract ## Objective To estimate the costβutility and costβeffectiveness of a 3βweek intensive exercise training (IET) program directly following hospital discharge in patients with rheumatic diseases. ## Methods Patients with arthritis who were admitted to the hospital because of a disease
Ongoing hepatitis B virus replication in the presence of antibody to HBeAg can be observed in patients with active liver disease. These forms of chronic hepatitis B have been described as having a poor prognosis. We have conducted a randomized controlled trial to assess the efficacy of lymphoblastoi